iAMP COVID-19 SANO Assay
A real-time fluorescent RT-isothermal assay based on Atila’s proprietary isothermal amplification technology intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal swabs and saliva specimens from individuals with signs and symptoms of infection who are suspected of COVID-19.
Fast. Simple. Accurate.
Product number 81104
Product number 80762
Product number 80812
Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient’s infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.
The iAMP COVID-19 SANO Assay is intended for use by trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time nucleic acid amplification and in vitro diagnostic procedures.
* The iAMP COVID-19 Sample Collection Device and iAMP COVID-19 Sample Collection Device NP are for Research Use Only; not for use in diagnostic procedures. Not yet available as CE marked product.
Conditions of sale
To read the end user conditions of sale for this product please visit our Resource center.
Lumipulse G SARS-CoV-2 Ag was the first high-sensitive nucleocapsid protein antigen assay launched on a fully automated chemiluminescent platform.
Jan 6, 2022
During this webinar Dr. Francesco Bonella (MD - Center for Interstitial & Rare Lung Disease, Department of Pulmonology, Ruhrlandklinik University...
Oct 19, 2020
Several fully automated and CLEIA-based LUMIPULSE G1200 systems from Fujirebio are right now performing fast, high sensitivity SARS CoV-2 antigen...
Aug 26, 2020
FAQHow does the coronavirus disease Covid-19 impact Fujirebio's operations?
Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
iAMP COVID-19 Detection Kit
Product number 80767, 80762 -
Qualitative nucleic acid detection of SARS-CoV-2 (COVID-19) on naso- or oropharyngeal swabs without pre-treatment.CE marked
Power-Gene 9600 Plus
Product number 80737 -
Power-Gene 9600 Plus adopts Ferrotec specially-made Peltier, advanced fiber optic technology, new global wide-range power supply, the unique patented block dissipation technology and bottom detection mode, which provides better heating/cooling rate, temperature accuracy, uniformity and stability.CE marked
DiaPlexQ™ Flu A/B & SARS-CoV-2
Product number 81131 -
Real-time RT-PCR test for the qualitative detection of HA gene from Influenza A/B virus and N and ORF1a gene from SARS-CoV-2 in nasopharyngeal swab.CE marked
DiaPlexQ™ SARS-CoV-2 (ORF1a, N, RdRp)
Product number 81132 -
Real-time RT-PCR test for the qualitative detection of SARS-CoV-2 nucleic acids in various sample types.CE marked
Lumipulse® G SARS-CoV-2 Ag
Product number 260340, 231869 -
For in vitro diagnostic (IVD) use with the Lumipulse G system for detection and quantitative measurement of SARS-CoV-2 nucleocapsid protein antigen in human nasopharyngeal swab or saliva. As a diagnostic tool for the confirmation of a SARS-CoV-2 infection.CE marked
Lumipulse® G SARS-CoV-2 S-IgG
Product number 232231 -
For in vitro diagnostic (IVD) use with the Lumipulse G system for the quantitative measurement of IgG-type antibodies SARS-CoV-2 spike protein (SARS-CoV-2 S-IgG) in specimens based on CLEIA technology by a specific two-step immunoassay method on the LUMIPULSE G System.CE marked
Lumipulse® G SARS-CoV-2 N-IgG
Product number 232323 -
For in vitro diagnostic (IVD) use with the Lumipulse G system for the quantitative measurement of IgG antibodies to SARS-CoV-2 nucleocapsid (N) protein in human serum or plasma. SARS-CoV-2 N antibody measurement is intended to be used as an aid in the assessment of immune response to the SARS-CoV-2 N protein.CE marked
Lumipulse® G KL-6 (Krebs von den Lungen)
Product number 233207 -
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of sialylated carbohydrate antigen, KL-6 in serum or plasma.CE marked
IL-6 (Interleukin) LPG
Product number 293423 -
For research use with the LUMIPULSE G system for the quantitative measurement of IL-6 in serum or plasma.For research use only